Literature DB >> 9777368

RGTA11, a new healing agent, triggers developmental events during healing of craniotomy defects in adult rats.

J Lafont1, B Baroukh, A Berdal, M L Colombier, D Barritault, J P Caruelle, J L Saffar.   

Abstract

RGTA are chemically defined compounds which proved to be very potent healing agents in various tissue repair models including skin, muscle and nerve. These chemicals are believed to protect endogenously released heparin-binding growth factors and enhance their bioavailability during healing. In craniotomy defects that do not heal spontaneously in adults, RGTA promoted dose-dependent skull closure. The aim of this work was to characterize, in the same model, the events associated with wound closure by studying the expression of the osteoblastic phenotype and the distribution of some matrix proteins during RGTA11-induced bone healing. Craniotomy defects in rats were implanted with collagen plasters soaked in a solution of RGTA11 (1.5 micrograms per piece). The skulls were removed 30 days after wounding, a stage of almost complete bone filling in treated samples. Bone formed only at the edges of the defect in controls, while it formed also at the center in the form of nodules in the treated samples. RGTA11 modified the amount and distribution of the tissues including bone in the wounds. In some RGTA11-treated samples, skull closure by bone occurred and the median suture was restored. In the treated defects, alkaline phosphatase-positive (osteoprogenitor) cells were far more numerous and were distributed differently. Type I and III collagen and fibronectin deposition was markedly enhanced in the bone compartment of the wounds. Secretory osteoblasts released type III collagen. Osteocalcin expression was enhanced by RGTA11. RGTA11 thus modified the healing pattern by increasing both the cellularity and the synthesis of a bone-competent extracellular matrix, thereby restoring the original anatomy of the skull. Flat bone regeneration can be triggered in adults through developmental events (i.e. nodule formation, secretion of type III collagen by osteoblasts, suture restoration...) that are no longer operative in the wounds of mature individuals.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9777368     DOI: 10.3109/08977199809017489

Source DB:  PubMed          Journal:  Growth Factors        ISSN: 0897-7194            Impact factor:   2.511


  7 in total

1.  Structure and epitope distribution of heparan sulfate is disrupted in experimental lung hypoplasia: a glycobiological epigenetic cause for malformation?

Authors:  Sophie M Thompson; Marilyn G Connell; Toin H van Kuppevelt; Ruoyan Xu; Jeremy E Turnbull; Paul D Losty; David G Fernig; Edwin C Jesudason
Journal:  BMC Dev Biol       Date:  2011-06-14       Impact factor: 1.978

2.  Reversal of abnormal collagen production in Crohn's disease intestinal biopsies treated with regenerating agents.

Authors:  C Alexakis; J P Caruelle; A Sezeur; J Cosnes; J P Gendre; H Mosnier; L Beaugerie; D Gallot; M Malafosse; D Barritault; P Kern
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

3.  Glycosaminoglycan mimetic associated to human mesenchymal stem cell-based scaffolds inhibit ectopic bone formation, but induce angiogenesis in vivo.

Authors:  Guilhem Frescaline; Thibault Bouderlique; Leyya Mansoor; Gilles Carpentier; Brigitte Baroukh; Fernando Sineriz; Marina Trouillas; Jean-Louis Saffar; José Courty; Jean-Jacques Lataillade; Dulce Papy-Garcia; Patricia Albanese
Journal:  Tissue Eng Part A       Date:  2013-07       Impact factor: 3.845

4.  An engineered biopolymer prevents mucositis induced by 5-fluorouracil in hamsters.

Authors:  Frédéric O Morvan; Brigitte Baroukh; Dominique Ledoux; Jean-Pierre Caruelle; Denis Barritault; Gaston Godeau; Jean-Louis Saffar
Journal:  Am J Pathol       Date:  2004-02       Impact factor: 4.307

Review 5.  Heparin-Mimicking Polymers: Synthesis and Biological Applications.

Authors:  Samantha J Paluck; Thi H Nguyen; Heather D Maynard
Journal:  Biomacromolecules       Date:  2016-10-14       Impact factor: 6.988

Review 6.  RGTA® or ReGeneraTing Agents mimic heparan sulfate in regenerative medicine: from concept to curing patients.

Authors:  Denis Barritault; Marie Gilbert-Sirieix; Kim Lee Rice; Fernando Siñeriz; Dulce Papy-Garcia; Christophe Baudouin; Pascal Desgranges; Gilbert Zakine; Jean-Louis Saffar; Johan van Neck
Journal:  Glycoconj J       Date:  2016-12-07       Impact factor: 2.916

7.  Periodontal reconstruction by heparan sulfate mimetic-based matrix therapy in Porphyromonas gingivalis-infected mice.

Authors:  Benjamin R Coyac; Laurent Detzen; Philippe Doucet; Brigitte Baroukh; Annie Llorens; Martine Bonnaure-Mallet; Marjolaine Gosset; Denis Barritault; Marie-Laure Colombier; Jean-Louis Saffar
Journal:  Heliyon       Date:  2018-08-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.